Clinico-genomic characterization of PALB2 -mutated pancreatic adenocarcinoma.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.4169
Abstract: 4169 Background: Pancreatic adenocarcinoma (PDAC) with germline (g) or somatic (s) mutations in BRCA1/2 and PALB2 exhibit unique molecular characteristics and predict response to platinum-based chemotherapy and PARP inhibition. However, distinct features of PALB2 and… read more here.
Keywords: clinico genomic; palb2; palb2 palb2; history ... See more keywords